Telo Genomics Corp. (TSXV:TELO)
0.0400
0.00 (0.00%)
Sep 4, 2026, 2:30 PM EST
Telo Genomics Balance Sheet
Financials in millions CAD. Fiscal year is July - June.
Millions CAD. Fiscal year is Jul - Jun.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Cash & Equivalents | 0.98 | 0.79 | 0.8 | 2.67 | 2.69 | 3.64 |
Cash & Short-Term Investments | 0.98 | 0.79 | 0.8 | 2.67 | 2.69 | 3.64 |
Cash Growth | -21.88% | -0.84% | -70.22% | -0.73% | -25.95% | 294.85% |
Other Receivables | 0.03 | 0.03 | 0.03 | 0.06 | 0.04 | 0.1 |
Receivables | 0.03 | 0.03 | 0.03 | 0.06 | 0.04 | 0.1 |
Prepaid Expenses | 0.02 | 0.08 | 0.09 | 0.11 | 0.06 | 0.03 |
Total Current Assets | 1.03 | 0.89 | 0.92 | 2.84 | 2.79 | 3.76 |
Property, Plant & Equipment | 0.17 | 0 | 0.01 | 0.04 | 0.02 | - |
Other Intangible Assets | 0.03 | 0.01 | 0.04 | 0.04 | 0.02 | 0.08 |
Total Assets | 1.22 | 0.91 | 0.97 | 2.93 | 2.83 | 3.84 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Accounts Payable | 0.84 | 0.33 | 0.27 | 0.15 | 0.19 | 0.1 |
Accrued Expenses | 0.04 | 0.07 | 0.11 | 0.13 | 0 | 0.01 |
Short-Term Debt | 1.18 | - | - | - | - | - |
Current Portion of Long-Term Debt | - | - | - | 0.03 | - | - |
Total Current Liabilities | 2.11 | 0.4 | 0.38 | 0.31 | 0.19 | 0.11 |
Long-Term Debt | - | - | - | - | 0.04 | 0.04 |
Total Liabilities | 2.19 | 0.4 | 0.38 | 0.31 | 0.23 | 0.15 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Common Stock | 24.62 | 24.57 | 22.35 | 21.69 | 19.11 | 18.23 |
Additional Paid-In Capital | 6.58 | 6.44 | 6.07 | 6 | 5.79 | 5.64 |
Retained Earnings | -32.18 | -30.55 | -27.83 | -25.12 | -22.3 | -20.19 |
Comprehensive Income & Other | - | 0.05 | - | 0.04 | - | - |
Shareholders' Equity | -0.97 | 0.51 | 0.59 | 2.61 | 2.6 | 3.69 |
Total Liabilities & Equity | 1.22 | 0.91 | 0.97 | 2.93 | 2.83 | 3.84 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Total Debt | 1.32 | - | - | 0.03 | 0.04 | 0.04 |
Net Cash (Debt) | -0.34 | 0.79 | 0.8 | 2.64 | 2.65 | 3.6 |
Net Cash Growth | - | -0.84% | -69.86% | -0.46% | -26.24% | 308.24% |
Net Cash Per Share | -0.00 | 0.01 | 0.01 | 0.04 | 0.05 | 0.08 |
Filing Date Shares Outstanding | 100.43 | 100.43 | 74.56 | 71.31 | 59.42 | 57.49 |
Total Common Shares Outstanding | 100.43 | 100.02 | 74.56 | 71.16 | 59.42 | 55.54 |
Working Capital | -1.08 | 0.5 | 0.54 | 2.53 | 2.6 | 3.65 |
Book Value Per Share | -0.01 | 0.01 | 0.01 | 0.04 | 0.04 | 0.07 |
Tangible Book Value | -1 | 0.5 | 0.55 | 2.57 | 2.58 | 3.61 |
Tangible Book Value Per Share | -0.01 | 0.01 | 0.01 | 0.04 | 0.04 | 0.06 |
Machinery | 0.15 | 0.15 | 0.14 | 0.14 | 0.1 | 0.07 |